EAM
DNA icon

Erste Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Erste Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.9M Buy
2,536,939
+589,211
+30% +$4.93M 0.2% 117
2026
Q1 		$10.7M Sell
1,947,728
-52,272
-3% -$435K 0.1% 191
2025
Q4 		$16.6M Sell
2,000,000
-200,000
-9% -$2.15M 0.14% 148
2025
Q3 		$29.1M Buy
2,200,000
+200,000
+10% +$2.39M 0.28% 95
2025
Q2 		$22.5M Buy
2,000,000
+350,000
+21% +$2.71M 0.19% 114
2025
Q1 		$9.4M Buy
1,650,000
+910,668
+123% +$9.28M 0.12% 161
2024
Q4 		$6.98M Buy
739,332
+239,332
+48% +$2.05M 0.09% 206
2024
Q3 		$4.08M Buy
500,000
+300,000
+150% +$3.01M 0.05% 262
2024
Q2 		$2.67M Sell
200,000
-70,000
-26% -$2.09M 0.04% 279
2024
Q1 		$12.5M Hold
270,000
– – 0.17% 134
2023
Q4 		$18.3M Buy
270,000
+59,806
+28% +$3.66M 0.27% 106
2023
Q3 		$15.2M Hold
210,194
– – 0.26% 104
2023
Q2 		$15.6M Buy
210,194
+50,000
+31% +$2.96M 0.28% 102
2023
Q1 		$8.52M Buy
160,194
+52,500
+49% +$3.33M 0.16% 151
2022
Q4 		$7.28M Buy
107,694
+16,444
+18% +$1.51M 0.15% 158
2022
Q3 		$11.4M Buy
91,250
+16,250
+22% +$1.94M 0.26% 110
2022
Q2 		$7.14M Buy
75,000
+32,500
+76% +$3.96M 0.16% 157
2022
Q1 		$6.85M Buy
+42,500
New +$8.27M 0.13% 186

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Erste Asset Management's DNA Position: Q2 2026 in Review

Erste Asset Management increased its Ginkgo Bioworks (DNA) stake by 30% in Q2 2026, buying an estimated $4.93M and bringing the position to 2,536,939 shares worth $25.9M. The position accounts for 0.2% of the portfolio, ranked #117.

Erste Asset Management first reported a position in DNA in Q1 2022 and has held it in 18 quarters since. The position peaked at $29.1M in Q3 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Erste Asset Management held 2,536,939 shares of Ginkgo Bioworks worth $25.9M as of Q2 2026.
  • Erste Asset Management bought 589,211 Ginkgo Bioworks shares in Q2 2026, an estimated $4.93M.
  • Ginkgo Bioworks made up 0.2% of Erste Asset Management's portfolio in Q2 2026, its #117 holding.
  • Erste Asset Management first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 18 quarters since.
  • Erste Asset Management's Ginkgo Bioworks position peaked at $29.1M in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.